$MRNA earnings: what history says about next-day moves
How MRNA has reacted before
| Report | Next-day move |
|---|---|
| Jul 2026 | -10.8% |
| May 2026 | -1.2% |
| Feb 2026 | +5.3% |
| Aug 2025 | -6.6% |
| Feb 2025 | +3.4% |
| Nov 2024 | -3.0% |
Median absolute move 4.3% · higher 2 of 6 · n=6
Moderna, Inc. Common Stock reported $145 million in Q2 revenue, citing growth from international markets and strategic partnerships, while reaffirming up to 10% revenue growth guidance for 2026.
How $MRNA has reacted to earnings
| Report | Next-day |
|---|---|
| Jul 2026 | -10.8% |
| May 2026 | -1.2% |
| Feb 2026 | +5.3% |
| Aug 2025 | -6.6% |
| Feb 2025 | +3.4% |
| Nov 2024 | -3.0% |
Base rate (n=6):
- Median absolute next-day move: 4.3%
- Higher next day: 2 of 6
- Biggest up day: +5.3%
- Biggest down day: -10.8%